| 臺大學術典藏 |
2021-09-04T05:16:22Z |
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
|
JIA-HORNG KAO; Jeng W.-J.; Ning Q.; Su T.-H.; Tseng T.-C.; Ueno Y.; Yuen M.-F. |
| 臺大學術典藏 |
2021-09-04T05:16:22Z |
Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma
|
Wu C.-H.; Liang P.-C.; Su T.-H.; Lin M.-C.; Chang Y.-H.; Shih T.T.-F.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Response to letter to the editor “Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy”
|
Lin C.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Liu C.-J.; Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
Su T.-H.; Hsu S.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study
|
Yu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients
|
Liu M.; Tseng T.-C.; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H. |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment
|
Tseng T.-C.; Choi J.; Nguyen M.H.; Peng C.-Y.; Siakavellas S.; Papatheodoridis G.; Wang C.-C.; Lim Y.-S.; Lai H.-C.; Trinh H.N.; Wong C.; Wong C.; Zhang J.; Li J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:19Z |
Response to letter to the editor “The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma”
|
Cheng Y.-M.; Tzeng I.-S.; JIA-HORNG KAO; Wang C.-C. |
| 臺大學術典藏 |
2021-09-04T05:16:19Z |
The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma
|
Wang C.-C.; Tseng K.-C.; Tzeng I.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:19Z |
Artificial intelligence in precision medicine in hepatology
|
Su T.-H.; Wu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
|
Huang S.-C.; Liao S.-H.; Su T.-H.; Jeng Y.-M.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
The metabolic profiles and body composition of lean metabolic associated fatty liver disease
|
Cheng Y.-M.; JIA-HORNG KAO; Wang C.-C. |
| 臺大學術典藏 |
2021-09-04T05:16:18Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Reply to “Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia”
|
Yu M.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:16Z |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Yu M.-L. |
| 臺大學術典藏 |
2019-10-14T05:52:27Z |
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma
|
Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU |
| 臺大學術典藏 |
2019-10-14T05:52:27Z |
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma
|
Li, Yung-Tsung;Wu, Hui-Lin;Jia-Horng Kao;Cheng, Huei-Ru;Ming-Chih Ho;Wang, Chih-Chiang;Pei-Jer Chen;Ding-Shinn Chen;Chun-Jen Liu; Li, Yung-Tsung; Wu, Hui-Lin; JIA-HORNG KAO; Cheng, Huei-Ru; MING-CHIH HO; Wang, Chih-Chiang; PEI-JER CHEN; DING-SHINN CHEN; CHUN-JEN LIU |
| 臺大學術典藏 |
2019-09-09T00:55:30Z |
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B
|
Papatheodoridis, George V.; Bansal, Aruna T.; Plesniak, Robert; Liaw, Yun Fan; Motoc, Adriana; Foster, Graham R.; He, Hua; Wei, Lai; JIA-HORNG KAO; JIA-HORNG KAO;Wei, Lai;He, Hua;Foster, Graham R.;Motoc, Adriana;Liaw, Yun Fan;Plesniak, Robert;Bansal, Aruna T.;Papatheodoridis, George V.;Chen, Xiaoping;Piratvisuth, Teerha;Lampertico, Pietro;Wat, Cynthia;Pavlovic, Vedran; Pavlovic, Vedran; Wat, Cynthia; Lampertico, Pietro; Piratvisuth, Teerha; Chen, Xiaoping |
| 臺大學術典藏 |
2019-09-09T00:55:30Z |
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B
|
Papatheodoridis, George V.; Bansal, Aruna T.; Plesniak, Robert; Liaw, Yun Fan; Motoc, Adriana; Foster, Graham R.; He, Hua; Wei, Lai; JIA-HORNG KAO; JIA-HORNG KAO;Wei, Lai;He, Hua;Foster, Graham R.;Motoc, Adriana;Liaw, Yun Fan;Plesniak, Robert;Bansal, Aruna T.;Papatheodoridis, George V.;Chen, Xiaoping;Piratvisuth, Teerha;Lampertico, Pietro;Wat, Cynthia;Pavlovic, Vedran; Pavlovic, Vedran; Wat, Cynthia; Lampertico, Pietro; Piratvisuth, Teerha; Chen, Xiaoping |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:36:15Z |
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy
|
HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-JEN LIU;HUNG-CHIH YANG;Tseng, Tai-Chung;KAI-WEN HUANG;CHEN-HUA LIU;Liao, Chun-Hsun;TUNG-HUNG SU; TUNG-HUNG SU; Liao, Chun-Hsun; CHEN-HUA LIU; KAI-WEN HUANG; Tseng, Tai-Chung |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:28:14Z |
Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:28:14Z |
Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:20:11Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:20:11Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:03Z |
Prevention of mother-to-child transmission: the key of hepatitis B virus elimination
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Review article: the prevention of hepatitis B-related hepatocellular carcinoma
|
C.-L. Lin;J.-H. Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
|
Ming-Hung Hu;Tzu-Ting Huang;Tzu-I Chao;Li-Ju Chen;Yen-Lin Chen;Ming-Hsien Tsai;Chun-Yu Liu;Jia-Horng Kao;Kuen-Feng Chen; JIA-HORNG KAO |
